 | Clifford Woolf MD, PhD, Co-Founder & Chair of the Scientific Advisory Board Dr. Woolf's research into the molecular mechanisms of pain has led to numerous scientific breakthroughs, including the identification of the role of "central sensitization" in neuropathic pain. Dr Woolf was the first to discover the involvement of NGF in inflammatory pain His recent work identifying the role of GCH1 in human neuropathic pain is one of the core programs being developed at Solace Pharmaceuticals. Dr. Woolf is currently the Richard Kitz Chair of Anesthesia Research at Harvard Medical School and Massachusetts General Hospital. In addition to publishing over 250 scientific articles, Dr. Woolf is an esteemed consultant to numerous large pharmaceutical companies. |
 | Allan Basbaum PhD, Co-Founder & Scientific Advisory Board Member Dr. Basbaum is a leader in understanding the molecular basis for pharmacological intervention in neuropathic pain. Dr. Basbaum is a Professor of Anatomy at University of California, San Francisco. Dr. Basbaum advises numerous companies developing pain medicine. He is the editor-in-chief of the journal, Pain, and has published over 220 papers in top tier journals including a recent popular press review entitled, "Toward better pain control" in Scientific American. |
 | Bruce Bean PhD, Co-Founder & Scientific Advisory Board Member Dr. Bean is a Professor of Neurobiology at Harvard Medical School where he oversees a leading research lab studying the biophysics of sodium, calcium, and potassium ion signaling in relation to pain processing. Dr. Bean's scientific achievements have been recognized through prestigious awards from the Rita Allen Foundation and the McKnight Foundation. |
 | Joyce DeLeo PhD, Co-Founder & Scientific Advisory Board Member Dr. DeLeo is a leader in characterizing the role of glia cells, the non-neuronal cells in the central nervous system, in the central processing of pain. Dr. DeLeo is a former Fulbright scholar who completed her post-doctoral research at the Max Planck Institute for Psychiatry in Germany. Dr. DeLeo is currently the Irene Heinz Given Endowed Professor of Pharmacology and Professor of Anesthesiology at Dartmouth Medical School as well as the Director of the Dartmouth Neuroscience Center. |
 | Roy Freeman MD, Co-Founder & Scientific Advisory Board Member Dr. Freeman is a Professor of Neurology at Harvard Medical School and the Director of the Center for Autonomic and Peripheral Nerve Disorders at Beth Israel Deaconess Medical Center. Dr. Freeman is Solace's lead clinical consultant as the company organizes its first clinical trial |
 | Lee Simon MD, Co-Founder & Scientific Advisory Board Member Dr. Simon is a Professor of Rheumatology, Harvard Medical School. Dr. Simon is the former Division Director of Analgesic, Anti-inflammatory & Ophthalmologic Drug Products at the FDA and has overseen numerous reviews of drug therapies for the treatment of pain. Dr. Simon consults with companies developing pain therapies, including several large pharmaceutical companies. |
 | Tony Yaksh PhD, Co-Founder & Scientific Advisory Board Member Dr. Yaksh is a Professor and the Vice Chairman for Research in the Department of Anesthesiology at the University of California, San Diego. Dr. Yaksh is a pioneer in studying the central nervous system pharmacology of different drugs using intrathecal delivery for academic and corporate partners, including Medtronic and Cognetix. |